ArticleJournal of medicinal chemistry2024

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.

Esra Balıkçı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.